search
Back to results

A Single-case Design to Investigate a Compensatory Strategy Game Supporting Goal Management Training

Primary Purpose

Acquired Brain Injury, Executive Dysfunction, Goal Management Training

Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Intervention during phase B: Compensatory brain game supporting Goal Management Training intervention
Sponsored by
Klimmendaal Revalidatiespecialisten
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acquired Brain Injury

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age: 18 - 75 years Non-progressive acquired brain injury Minimal time post-onset of 3 months Outpatient rehabilitation Living independently at home Executive deficits (as determined on a neuropsychological assessment) Exclusion Criteria: Inability to speak/understand the Dutch language Severe psychiatric problems (history) Neurodegenerative disorders Substance abuse Severe cognitive comorbidity (i.e. dementia) Aphasia Neglect No access to a smartphone, and laptop or tablet Unable to look at a computer screen for 15 minutes Unable to operate a keyboard or computer mouse

Sites / Locations

  • Klimmendaal RevalidatiespecialistenRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

No Intervention

Arm Label

Baseline phase (Phase A)

Intervention phase (Phase B): Goal Management Training

Follow-up period

Arm Description

At the start of the study, all participants are assigned to the baseline phase (phase A). During phase A, patients do not receive interventions related to executive function problems. The start of the intervention phase (phase B) is determined randomly for each participant, given the restriction that phase A should last for at least three weeks (21 days) and at most five weeks (30 days). This means that phase B can start on any day between the 21th and the 30th days, resulting in a total of 10 possible assignments. So, in the first three weeks, all participants are in phase A. The duration of phase A will thus be different for each subject. Phase A acts as a control and is therefore compared with phase B.

During the intervention phase (phase B), all included participants will have 6 sessions of Goal Management Training (GMT; twice per week) in which two individual chosen IADL-tasks will be subdivided into multiple steps under guidance of a therapist using the GMT method. In addition participants play the compensatory brain game in which they are challenged to apply the learned GMT strategy in an imaginary and safe environment.

A follow-up period of three weeks takes place after phase B. During this follow-up period, patients receive no intervention.

Outcomes

Primary Outcome Measures

Change in performance on the Oxford Multiple Errands Test- Dutch version (OxMET-NL) from phase A to phase B
The target behavior will be assessed repeatedly, on a minimum of six occasions in phase A and B, in accordance with the recommendations of the What Works Clearinghouse and RoBiNT criteria (Tate et al., 2013). The OxMET-NL task is a computer-tablet based version of the Multiple Errands Test and is scored automatically. The task requires patients to buy six items and to answer two questions.

Secondary Outcome Measures

Change on the Visual Analogue Scale (VAS) from phase A to phase B to follow-up
Subjective experience of strategy use in daily life and during the performance of instrumental activities of daily living (IADL).
Change in performance on treatment goals as measured with the Goal Attainment Scale (GAS)
GAS is a mathematical technique for quantifying the achievement of goals set, used in rehabilitation. GAS is described as a method of scoring the extent to which patient's individual goals are achieved in the course of intervention. In effect, each patient has a own outcome measure, but this is scored in a standardized way as to allow statistical analysis. The achievement of each goal (IADL-task) can be measured on a 5-point scale ranging from -2 to +2. Outcomes can be quantified in a single aggregated goal attainment score. This method gives a numerical T-score which is normally distributed about a mean of 50 (if the goals are achieved precisely) with a standard deviation of around this mean of 10 (if the goals are overachieved or underachieved).
Change in performance on two trained IADL task (treatment goals)
Performance on two treatment goals is measured with a standardised scale which is similar to the one used by Bertens et al. (2015) and Dechamps et al. (2011). The tasks will be divided into multiple steps using the GMT method. Each task step will be assessed following a 3-point scale (ranging from 2=competent to 0=deficit). Total scores per task will be adjusted to a 100-point scale using the following formula: performance = (total score / (number of steps × 2)) × 100. Thus, a performance of 100% indicating perfect IADL task performance.
Change in everyday difficulties in activities/participation as measured on the Daily Living Questionnaire (DLQ-R-NL)
The Dutch version of the Daily Living Questionnaire measures how much mental or cognitive difficulty the participant generally has by performing daily activities.
Change in strategy use during the performance of trained and untrained IADL tasks
A self-designed questionnaire to examine self-reported strategy use will also be administered after the performance of the trained and untrained IADL tasks, based on the strategy questionnaire used by Frankenmolen, Fasotti, Kessels & Oosterman (2018), in order to measure strategy use in a traditional memory task. First, participants are openly asked which strategies they use during the performance of an IADL task. Subsequently, they are given a list with possible strategy components of GMT that one could use to perform a task and are asked to place a check mark next to each strategy that they had used.
Change in subjective experience of strategy use in daily life
GMT strategy use is assessed through an adjustment of the Strategy Use Inventory; SUI (Koning-Haanstra, Berg, & Deelman, 1990). Participants have to indicate how often they use a certain strategy in daily life situations using a 5-point rating scale ranging from 1 (never) to 5 (often). Average item scores are calculated.

Full Information

First Posted
December 2, 2022
Last Updated
June 28, 2023
Sponsor
Klimmendaal Revalidatiespecialisten
search

1. Study Identification

Unique Protocol Identification Number
NCT05737238
Brief Title
A Single-case Design to Investigate a Compensatory Strategy Game Supporting Goal Management Training
Official Title
Evaluation of a Compensatory Brain Game Supporting Goal Management Training Targeting Executive Function After Acquired Brain Injury Using Single-case Experimental Design Methodology
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 7, 2023 (Actual)
Primary Completion Date
February 1, 2024 (Anticipated)
Study Completion Date
February 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Klimmendaal Revalidatiespecialisten

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The main cognitive complaint in brain-injured patients is often the everyday disorganization caused by executive function (EF) deficits. In order to minimize the everyday disorganization, effective EF interventions are required. Interventions which incorporate compensatory strategies have the potential to enable patients to minimize disabilities, minimize participation problems and to function more independently in daily life. A well-known evidence-based intervention that incorporates compensatory strategies is Goal Management Training (GMT). GMT entails learning and applying an algorithm, in which a daily task is subdivided into multiple steps to handle executive difficulties of planning, and problem solving. To adopt the GMT strategy and ensure maximal profitability for patients, they have to learn to use the algorithm in different situations and tasks. Therefore, GMT is a comprehensive, time-consuming and thus labour-intensive treatment. Along with this, brain games become increasingly attractive as an (add-on) intervention, most notably in an effort to develop home-based personalized care. Until now, however, the rationale behind brain games is based on what can be considered the restorative approach (i.e. strengthening of executive problems) rather than practicing compensatory strategies, with little or no transfer to improvements in daily life functioning. This study therefore aims to assess the potential of a newly developed Brain Game, based on compensatory strategies, as an add-on to GMT to develop a shortened and partly home-based GMT intervention. The primary objective of this study is to assess whether the use of a compensatory brain game supported GMT treatment could be of interest in people with EF deficits after ABI, to improve goal achievement, their executive function performance during goal-related tasks, and their executive performance during an ecological valid shopping task. The study will be a multiple-baseline across individuals single-case experimental design (SCED). The study population consists of patients referred for outpatient cognitive rehabilitation. Participants eligible for the study must have executive deficits due to Acquired Brain Injury (ABI) of nonprogressive nature (i.e. TBI, stroke), with a minimum time post-onset of 3 months. Age has to be between 18 and 75 and participants have to live independently at home. Executive deficits will be assessed by extensive neuropsychological examination. Participants will be recruited from the outpatient clinic and the department of neurorehabilitation of Klimmendaal and Vogellanden. Four participants will be recruited.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acquired Brain Injury, Executive Dysfunction, Goal Management Training, Compensatory Strategy Training, Serious Gaming

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
A randomized Single-case Experimental Design (SCED) with a follow-up period of 1 month. Participants will be first assigned to a baseline phase (phase A). The start of the treatment phase (phase B) is determined randomly for each participant, given the restriction that the baseline phase (phase A) should last for at least three weeks (21 days) and at most five weeks (30 days). This means that the treatment phase can start on any day between the 21th and the 30th days. So, in the first three weeks, all participants are in the baseline condition. The duration of baseline will thus be different for each subject. Nonspecific effects, such as linear trends, retesting or non-specific recovery, can be controlled by this approach, since expected changes in level of performance due to treatment should parallel this stepwise onset of therapy procedure. Phase A acts as a control and is therefore compared with phase B.
Masking
Outcomes Assessor
Masking Description
The target behavior (i.e. performance on an untrained shopping task) will be measured repeatedly, on a minimum of six occasions in each phase where possible, in accordance with the recommendations of the What Works Clearinghouse and RoBiNT criteria (Tate et al., 2013). Repeated measures of target behavior will be assessed via the OxMET-NL task and is scored automatically: no assessor input is required to either save or score the main outcome data. The secondary outcome measure(s) are scored by an outcome assessor who is blind to the order in which the secondary outcome measure(s) were taken.
Allocation
Randomized
Enrollment
4 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Baseline phase (Phase A)
Arm Type
No Intervention
Arm Description
At the start of the study, all participants are assigned to the baseline phase (phase A). During phase A, patients do not receive interventions related to executive function problems. The start of the intervention phase (phase B) is determined randomly for each participant, given the restriction that phase A should last for at least three weeks (21 days) and at most five weeks (30 days). This means that phase B can start on any day between the 21th and the 30th days, resulting in a total of 10 possible assignments. So, in the first three weeks, all participants are in phase A. The duration of phase A will thus be different for each subject. Phase A acts as a control and is therefore compared with phase B.
Arm Title
Intervention phase (Phase B): Goal Management Training
Arm Type
Experimental
Arm Description
During the intervention phase (phase B), all included participants will have 6 sessions of Goal Management Training (GMT; twice per week) in which two individual chosen IADL-tasks will be subdivided into multiple steps under guidance of a therapist using the GMT method. In addition participants play the compensatory brain game in which they are challenged to apply the learned GMT strategy in an imaginary and safe environment.
Arm Title
Follow-up period
Arm Type
No Intervention
Arm Description
A follow-up period of three weeks takes place after phase B. During this follow-up period, patients receive no intervention.
Intervention Type
Behavioral
Intervention Name(s)
Intervention during phase B: Compensatory brain game supporting Goal Management Training intervention
Intervention Description
The investigational treatment is only given during the intervention phase (phase B), and consists of six treatment sessions. In the treatment sessions, patients learn and apply the GMT algorithm. This means that the multiple steps of the GMT as well as the actual performance of the IADL-task goals will be learned under guidance of a therapist. In order to facilitate generalization, patients will learn to use the algorithm during the performance of untrained tasks by playing the treatment supporting Plan Game. Because of this, patients are able to practice the application of the GMT algorithm independently at their own home. Besides, the intervention also includes a Plan Tool. This is a mobile application that can be used as an aid during the performance of (instrumental) activities of daily living (IADL) tasks in order to perform activities more independently. The GMT treatment sessions are given twice a week (max. 60 minutes for each attendance).
Primary Outcome Measure Information:
Title
Change in performance on the Oxford Multiple Errands Test- Dutch version (OxMET-NL) from phase A to phase B
Description
The target behavior will be assessed repeatedly, on a minimum of six occasions in phase A and B, in accordance with the recommendations of the What Works Clearinghouse and RoBiNT criteria (Tate et al., 2013). The OxMET-NL task is a computer-tablet based version of the Multiple Errands Test and is scored automatically. The task requires patients to buy six items and to answer two questions.
Time Frame
The target behavior (i.e. performance on the OxMET-NL) will be measured repeatedly, two times a week, for the duration of phase A (3 to 5 weeks) and phase B (3 weeks)
Secondary Outcome Measure Information:
Title
Change on the Visual Analogue Scale (VAS) from phase A to phase B to follow-up
Description
Subjective experience of strategy use in daily life and during the performance of instrumental activities of daily living (IADL).
Time Frame
The VAS will be assessed repeatedly, two times a week, for the duration of phase A (3 to 5 weeks), phase B (3 weeks) and follow-up (3 weeks)
Title
Change in performance on treatment goals as measured with the Goal Attainment Scale (GAS)
Description
GAS is a mathematical technique for quantifying the achievement of goals set, used in rehabilitation. GAS is described as a method of scoring the extent to which patient's individual goals are achieved in the course of intervention. In effect, each patient has a own outcome measure, but this is scored in a standardized way as to allow statistical analysis. The achievement of each goal (IADL-task) can be measured on a 5-point scale ranging from -2 to +2. Outcomes can be quantified in a single aggregated goal attainment score. This method gives a numerical T-score which is normally distributed about a mean of 50 (if the goals are achieved precisely) with a standard deviation of around this mean of 10 (if the goals are overachieved or underachieved).
Time Frame
pre-intervention, immediately following intervention and at three weeks follow-up
Title
Change in performance on two trained IADL task (treatment goals)
Description
Performance on two treatment goals is measured with a standardised scale which is similar to the one used by Bertens et al. (2015) and Dechamps et al. (2011). The tasks will be divided into multiple steps using the GMT method. Each task step will be assessed following a 3-point scale (ranging from 2=competent to 0=deficit). Total scores per task will be adjusted to a 100-point scale using the following formula: performance = (total score / (number of steps × 2)) × 100. Thus, a performance of 100% indicating perfect IADL task performance.
Time Frame
pre-intervention, immediately following intervention and at three weeks follow-up
Title
Change in everyday difficulties in activities/participation as measured on the Daily Living Questionnaire (DLQ-R-NL)
Description
The Dutch version of the Daily Living Questionnaire measures how much mental or cognitive difficulty the participant generally has by performing daily activities.
Time Frame
pre-intervention, immediately following intervention and at three weeks follow-up
Title
Change in strategy use during the performance of trained and untrained IADL tasks
Description
A self-designed questionnaire to examine self-reported strategy use will also be administered after the performance of the trained and untrained IADL tasks, based on the strategy questionnaire used by Frankenmolen, Fasotti, Kessels & Oosterman (2018), in order to measure strategy use in a traditional memory task. First, participants are openly asked which strategies they use during the performance of an IADL task. Subsequently, they are given a list with possible strategy components of GMT that one could use to perform a task and are asked to place a check mark next to each strategy that they had used.
Time Frame
pre-intervention, immediately following intervention and at three weeks follow-up
Title
Change in subjective experience of strategy use in daily life
Description
GMT strategy use is assessed through an adjustment of the Strategy Use Inventory; SUI (Koning-Haanstra, Berg, & Deelman, 1990). Participants have to indicate how often they use a certain strategy in daily life situations using a 5-point rating scale ranging from 1 (never) to 5 (often). Average item scores are calculated.
Time Frame
pre-intervention, immediately following intervention and at three weeks follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age: 18 - 75 years Non-progressive acquired brain injury Minimal time post-onset of 3 months Outpatient rehabilitation Living independently at home Executive deficits (as determined on a neuropsychological assessment) Exclusion Criteria: Inability to speak/understand the Dutch language Severe psychiatric problems (history) Neurodegenerative disorders Substance abuse Severe cognitive comorbidity (i.e. dementia) Aphasia Neglect No access to a smartphone, and laptop or tablet Unable to look at a computer screen for 15 minutes Unable to operate a keyboard or computer mouse
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dirk Bertens, Dr
Phone
0263526100
Email
d.bertens@klimmendaal.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elise Verhoog, MSc
Organizational Affiliation
Donders Institute for Brain, Cognition and Behaviour
Official's Role
Principal Investigator
Facility Information:
Facility Name
Klimmendaal Revalidatiespecialisten
City
Arnhem
State/Province
Gelderland
ZIP/Postal Code
6813 GG
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dirk Bertens, PhD
Phone
026 352 6100
Email
d.bertens@klimmendaal.nl
First Name & Middle Initial & Last Name & Degree
Elise Verhoog, MSc.

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

A Single-case Design to Investigate a Compensatory Strategy Game Supporting Goal Management Training

We'll reach out to this number within 24 hrs